Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings (ORGO) Income Statement


Organogenesis Holdings Income Statement

Last quarter (Q4 2022), Organogenesis Holdings's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, Organogenesis Holdings's net income was $―. See Organogenesis Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 336.38M-$ 468.06M$ 338.30M$ 260.98M$ 193.45M
Cost of Revenue
$ 77.91M-$ 114.20M$ 87.32M$ 75.95M$ 68.81M
Gross Profit
$ 258.47M-$ 353.86M$ 250.98M$ 185.03M$ 124.64M
Operating Expense
$ 243.88M-$ 280.94M$ 224.28M$ 214.49M$ 172.70M
Operating Income
$ 14.59M-$ 72.92M$ 26.70M$ -29.46M$ -48.06M
Net Non Operating Interest Income Expense
$ -2.04M-$ -7.24M$ -11.28M$ -9.00M$ -10.79M
Other Income Expense
$ -19.00K-$ -1.90M$ 2.34M$ -1.85M$ -5.90M
Pretax Income
$ 12.53M-$ 63.79M$ 17.76M$ -40.30M$ -64.75M
Tax Provision
$ 3.48M-$ -31.12M$ 530.00K$ 150.00K$ 84.00K
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ 9.05M-$ 94.90M$ 17.23M$ -41.10M$ -64.83M
Basic EPS
$ 0.13$ 0.12$ 0.74$ 0.17$ -0.44$ -0.94
Diluted EPS
$ 0.13$ 0.12$ 0.71$ 0.16$ -0.44$ -0.94
Basic Average Shares
$ 520.25M$ 130.07M$ 128.33M$ 107.74M$ 92.84M$ 69.32M
Diluted Average Shares
$ 529.51M$ 132.38M$ 133.66M$ 111.36M$ 92.84M$ 69.32M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 321.79M-$ 395.14M$ 311.60M$ 290.44M$ 241.51M
Net Income From Continuing And Discontinued Operation
$ 9.05M-$ 94.90M$ 17.23M$ -40.45M$ -64.83M
Normalized Income
$ 9.05M-$ 96.28M$ 15.05M$ -39.09M$ -60.41M
Interest Expense
$ 2.04M-$ 7.24M$ 11.28M$ 9.00M$ 10.79M
$ 14.57M-$ 71.02M$ 29.04M$ -31.31M$ -53.96M
$ 28.04M-$ 87.70M$ 37.23M$ -21.88M$ -46.98M
Currency in USD

Organogenesis Holdings Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis